News Announcement

Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Ichnos Glenmark Innovation (IGI) announces first presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/ Refractory Multiple Myeloma (r/rMM) at upcoming ASH Annual Meeting


दूसरी कैटेगरी